1,265 results on '"Saba, Nabil F."'
Search Results
2. Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact
3. Update on olfactory neuroblastoma
4. Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504
5. Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
6. Safety and Efficacy of MEDI0457 Plus Durvalumab in Patients With Human Papillomavirus-associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
7. A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
8. Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53
9. Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States
10. Artificial Intelligence in Head and Neck Cancer: A Systematic Review of Systematic Reviews
11. Management of Older Patients with Head and Neck Cancer: A Comprehensive Review
12. Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
13. Associations of differentially expressed genes with psychoneurological symptoms in patients with head and neck cancer: A longitudinal study
14. Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent
15. Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer
16. Cancer metabolism and carcinogenesis
17. Circulating short chain fatty acids and fatigue in patients with head and neck cancer: A longitudinal prospective study
18. Genomic and immune profiling of rare non-squamous sinonasal tumors.
19. Feasibility study of a personalized tumor membrane vesicle vaccine immunotherapy for head and neck squamous cell carcinoma (HNSCC).
20. Association of artificial intelligence–derived collagen disorder architecture (CoDA) features with survival outcome and objective response to immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma.
21. A randomized, double-blind, placebo-controlled phase II study of adjuvant pembrolizumab versus placebo in patients with head and neck squamous cell cancers at high risk for recurrence: The PATHWay study.
22. Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C.
23. Associations of inflammation with neuropsychological symptom cluster in patients with Head and neck cancer: A longitudinal study
24. Insurance Authorization and Access to Proton Therapy for Patients With Head and Neck Cancers
25. Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral Blood
26. Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma
27. 434 Investigating the metabolic-inflammatory mechanisms of cachexia symptoms in head and neck cancer patient plasma via multiomics integration of the metabolome, lipidome, and inflammation cytokines
28. ThyroSeq overview on indeterminate thyroid nodules: An institutional experience
29. Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care ‐ A systematic review
30. ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development
31. The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
32. Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review
33. Locally advanced high-risk HPV related oropharyngeal squamous cell carcinoma (OPSCC); have we forgotten it is a different disease?
34. To Scan or Not to Scan: The Dilemma of Posttreatment Imaging Surveillance of Head and Neck Cancer
35. Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab
36. Stereotactic Body Radiotherapy as a Curative Treatment for De Novo Mucosal Carcinoma of the Head and Neck: A Feasible Alternative Option for Fragile Patients with Small Lesion: A Systematic Review †.
37. Defining HPV-specific B cell responses in patients with head and neck cancer
38. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
39. Head and neck cancer
40. De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
41. Prognostic biomarkers in patients with human immunodeficiency virus‐positive disease with head and neck squamous cell carcinoma
42. HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer
43. Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)
44. Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer
45. Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck
46. Combinatorial approaches targeting the EGFR family and c-Met in SCCHN
47. Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
48. Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
49. A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311
50. Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.